Background: Coronary artery disease introduced as the most prevalent cause of mortality all over the world. There is limited published data on which type of chest physiotherapy and breathing exercises are recommended to cardiac patients after surgery.
Objectives: To determine the prevalence of chest physiotherapy and breathing exercise for the post cardiac patients.
To determine the type of chest physiotherapy and breathing exercise for the post cardiac patients.
Methodology: A Cross-sectional survey was conducted on 150 physiotherapists from March to August 2018 selected via convenience sampling technique. Data was collected from Tabba cardiac Hospital and NICVD Karachi, using self-structured questionnaire for prevalence and type of exercise. Data was analyzed using SPSS v.21.
Results: According to the results, the prevalence of chest physiotherapy and breathing exercise for the cardiac patients was 80%. The most frequent type of exercise was deep breathing 92%, diaphragmatic breathing 90%, coughing80%, relaxation techniques 72% and chest wall Vibration 70%. The less used treatments were positive expiratory pressure (PEP) device breathing (21.3%) and inspiratory resistance positive expiratory pressure (IR-PEP) (12.5%). Recommendations to continue breathing exercises after discharge varied from not at all up to 3 months after surgery.
Conclusion: Physiotherapy and Breathing exercise are mostly used in post-operative cardiac procedures. Every Hour breathing activities, diaphragmatic breathing and pressed together lip breathing exercise the highly recommended regime practiced. Guideline for the duration after discharge varies
Chest physiotherapy,ACBTs,therapeutic modalities
Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.
Illian DN, Siregar ES, Sumaiyah S, Utomo AR, Nuryawan A, Basyuni M
Heliyon. 2021; 7(1): e06001
Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites.
Khan T, Khan MA, Mashwani ZU, Ullah N, Nadhman A
Biocatalysis and agricultural biotechnology. 2021; 31(): 101890
Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals.
Hosseini SA, Zahedipour F, Sathyapalan T, Jamialahmadi T, Sahebkar A
BioFactors (Oxford, England). 2021; ():
Targeting androgen receptor signaling with MicroRNAs and Curcumin: a promising therapeutic approach for Prostate Cancer Prevention and intervention.
Javed Z, Khan K, Rasheed A, Sadia H, Shahwani MN, Irshad A, Raza S, Salehi B, Sharifi-Rad J, Suleria HAR, Cruz-Martins N, Quispe C
Cancer cell international. 2021; 21(1): 77
Therapeutic opportunities of edible antiviral plants for COVID-19.
Patel B, Sharma S, Nair N, Majeed J, Goyal RK, Dhobi M
Molecular and cellular biochemistry. 2021; ():
A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.
Kyriakou S, Cheung W, Mantso T, Mitsiogianni M, Anestopoulos I, Veuger S, Trafalis DT, Franco R, Pappa A, Tetard D, Panayiotidis MI
Investigational new drugs. 2021; ():
Topical Delivery of Nivolumab, a Therapeutic Antibody, by Fractional Laser and Pneumatic Injection.
Christensen RL, Omland SH, Persson DP, Husted S, Haedersdal M, Olesen UH
Lasers in surgery and medicine. 2021; 53(1): 154-161
Targeting Glioblastoma: The Current State of Different Therapeutic Approaches.
Khan I, Mahfooz S, Elbasan EB, Karacam B, Oztanir MN, Hatiboglu MA
Current neuropharmacology. 2021; ():